HUMA - Humacyte, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$3.00
DETAILS
HIGH:
$3.00
LOW:
$3.00
MEDIAN:
$3.00
CONSENSUS:
$3.00
UPSIDE:
170.27%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 2.0 | 0 | 0 | 1.6 | 1.3 | 1.5 | 6.2 |
| Cost of Revenue | 17.0 | 7.2 | 76.5 | 8.3 | 61.3 | 54.1 | 75.6 |
| Gross Profit | (15.0) | (7.2) | (76.5) | (6.7) | (60.1) | (52.6) | (69.4) |
| Operating Expenses | |||||||
| R&D Expenses | 69.3 | 88.6 | 76.5 | 63.3 | 61.3 | 54.1 | 75.6 |
| SG&A Expenses | 31.2 | 25.8 | 20.4 | 22.9 | 21.1 | 12.0 | 16.3 |
| Other Expenses | (8.0) | (7.2) | (73.4) | (8.3) | (61.3) | (54.1) | (75.6) |
| Operating Expenses | 92.4 | 107.2 | 23.5 | 77.9 | 21.1 | 12.0 | 16.3 |
| Operating Income | |||||||
| Operating Income | (107.4) | (114.4) | (100.0) | (84.6) | (81.2) | (64.6) | (85.7) |
| Interest Expense | 11.2 | 9.3 | 6.6 | 6.2 | 4.3 | 2.2 | 2.3 |
| Interest Income | 2.6 | 4.1 | 5.5 | 2.6 | 0.0 | 0.3 | 0.3 |
| Profitability | |||||||
| EBITDA | (100.1) | (132.2) | (96.5) | (76.4) | (73.0) | (56.2) | (78.9) |
| EBIT | (107.4) | (139.4) | (104.2) | (84.6) | (81.2) | (64.6) | (85.7) |
| Income Before Tax | (40.8) | (148.7) | (110.8) | (12.0) | (26.5) | (66.5) | (85.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (40.8) | (148.7) | (110.8) | (12.0) | (26.5) | (66.5) | (85.4) |
| Per Share Data | |||||||
| EPS (Basic) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -5.52 | -4.25 |
| EPS (Diluted) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -5.52 | -4.25 |
| Shares Outstanding | 158.2 | 118.5 | 103.4 | 103.1 | 40.0 | 12.4 | 20.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 50.5 | 44.9 | 80.4 | 149.8 | 217.5 | 39.9 | 93.7 |
| Short-Term Investments | 0 | 0 | 0 | 2.1 | 8 | 0 | 0 |
| Net Receivables | 0.4 | 0 | 0 | 0.0 | 0.2 | 0.1 | 0.6 |
| Inventory | 13.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.3 | 2.9 | 2.8 | 2.3 | 0 | 0 | 0 |
| Total Current Assets | 67.8 | 47.9 | 83.3 | 154.2 | 229.3 | 41.4 | 95.0 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 47.7 | 38.6 | 44.1 | 50.1 | 57.2 | 65.2 | 73.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.7 | 51.5 | 0.8 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 48.6 | 90.0 | 44.9 | 50.1 | 57.2 | 65.2 | 73.7 |
| Total Assets | 116.4 | 137.9 | 128.2 | 204.3 | 286.5 | 106.7 | 168.7 |
| Current Liabilities | |||||||
| Account Payables | 5.4 | 4.5 | 6.5 | 1.6 | 2.1 | 2.3 | 3.3 |
| Short-Term Debt | 2.4 | 0 | 0 | 8.6 | 0 | 2.5 | 1.5 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.5 | 7.4 | 5.3 | 4.2 | 4.1 | 1.2 | (1.5) |
| Total Current Liabilities | 18.4 | 20.0 | 18.4 | 19.6 | 11.1 | 11.2 | 10.8 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 35.4 | 0 | 38.6 | 20.3 | 27.4 | 0.8 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 32.5 | 157.0 | 41.3 | 28.6 | 104.2 | 0.1 | 0 |
| Total Non-Current Liabilities | 94.9 | 170.6 | 96.2 | 67.8 | 153.3 | 24.8 | 25.6 |
| Total Liabilities | 113.3 | 190.5 | 114.7 | 87.4 | 164.4 | 36.0 | 36.5 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (726.8) | (686.0) | (537.3) | (426.5) | (414.6) | (388.1) | (321.6) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 3.1 | (52.7) | 13.5 | 116.9 | 122.2 | 70.7 | 132.2 |
| Total Liabilities & Equity | 116.4 | 137.9 | 128.2 | 204.3 | 286.5 | 106.7 | 168.7 |
| Debt Metrics | |||||||
| Total Debt | 64.8 | 16.5 | 57.5 | 50.1 | 51.2 | 28.9 | 28.7 |
| Net Debt | 14.3 | (28.4) | (23.0) | (99.7) | (166.3) | (11.1) | (65.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (40.8) | (148.7) | (110.8) | (12.0) | (26.5) | (66.5) | (85.4) |
| Depreciation & Amortization | 5.3 | 7.2 | 7.7 | 8.2 | 8.2 | 8.4 | 6.7 |
| Stock-Based Compensation | 9.8 | 6.1 | 6.8 | 6.2 | 10.1 | 0 | 4.5 |
| Change in Working Capital | (23.4) | 0.3 | 6.6 | 1.0 | (0.6) | (2.4) | 0.5 |
| Other Non-Cash Items | (55.9) | 36.9 | 16.4 | (74.6) | (72.5) | 4.9 | 6.2 |
| Operating Cash Flow | (105.0) | (98.1) | (73.3) | (71.1) | (81.2) | (55.6) | (71.8) |
| Investing Activities | |||||||
| Capital Expenditure | (0.9) | (1.6) | (2.3) | (1.0) | (0.2) | (0.3) | (8.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (10.1) | (8) | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 2.1 | 16 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (0.9) | (1.6) | (0.2) | 4.8 | (8.2) | (0.3) | (8.1) |
| Financing Activities | |||||||
| Net Debt Issuance | 36.4 | (2.6) | 5.7 | (2.0) | 27.9 | 1.8 | (1.3) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (88.3) | 27.7 | (1.8) | 0.5 | 239.1 | 0 | 1.2 |
| Financing Cash Flow | 61.5 | 114.2 | 4.5 | (1.4) | 267.0 | 2.1 | (0.1) |
| Cash Position | |||||||
| Net Change in Cash | (44.4) | 14.5 | (69.2) | (67.7) | 177.6 | 39.9 | (80.0) |
| Cash at Beginning | 95.3 | 80.8 | 149.8 | 217.5 | 39.9 | 0 | 173.7 |
| Cash at End | 50.9 | 95.3 | 80.6 | 149.8 | 217.5 | 39.9 | 93.7 |
| Free Cash Flow | (105.9) | (99.7) | (75.6) | (72.2) | (81.4) | (55.9) | (79.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2.0 | 0 | 0 | 1.6 | 1.3 | 1.5 | 6.2 |
| Gross Profit | (15.0) | (7.2) | (76.5) | (6.7) | (60.1) | (52.6) | (69.4) |
| Operating Income | (107.4) | (114.4) | (100.0) | (84.6) | (81.2) | (64.6) | (85.7) |
| Net Income | (40.8) | (148.7) | (110.8) | (12.0) | (26.5) | (66.5) | (85.4) |
| EPS (Diluted) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -5.52 | -4.25 |
| Balance Sheet | |||||||
| Cash & Equivalents | 50.5 | 44.9 | 80.4 | 149.8 | 217.5 | 39.9 | 93.7 |
| Total Assets | 116.4 | 137.9 | 128.2 | 204.3 | 286.5 | 106.7 | 168.7 |
| Total Debt | 64.8 | 16.5 | 57.5 | 50.1 | 51.2 | 28.9 | 28.7 |
| Stockholders' Equity | 3.1 | (52.7) | 13.5 | 116.9 | 122.2 | 70.7 | 132.2 |
| Cash Flow | |||||||
| Operating Cash Flow | (105.0) | (98.1) | (73.3) | (71.1) | (81.2) | (55.6) | (71.8) |
| Capital Expenditure | (0.9) | (1.6) | (2.3) | (1.0) | (0.2) | (0.3) | (8.1) |
| Free Cash Flow | (105.9) | (99.7) | (75.6) | (72.2) | (81.4) | (55.9) | (79.9) |